All participants had a diagnosis of LS, including 54 with a pathogenic variant in MSH2 (34%), 39 in MSH6 (25%), 38 in MLH1 (24%), 17 in PMS2 (11%), and 4 in EPCAM (3%). This evidence concerns the gene MSH6 and Leigh syndrome.